UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001158
Receipt number R000001408
Scientific Title Laparoscopy-assisted hepatectomy
Date of disclosure of the study information 2008/05/15
Last modified on 2008/05/15 17:15:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Laparoscopy-assisted hepatectomy

Acronym

Laparoscopy-assisted hepatectomy

Scientific Title

Laparoscopy-assisted hepatectomy

Scientific Title:Acronym

Laparoscopy-assisted hepatectomy

Region

Japan


Condition

Condition

Primary hepatic cancer
Metastatic liver cancer
Benign liver disease
Doner

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim for this study is to assess the safety and surgical outcome of laparoscopy-assisted hepatectomy.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Postoperative hospital stay

Key secondary outcomes

Operation time
Blood loss


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Surgical procedure
Cholecystectomy and mobilization of the liver are performed with pneumoperitoneum. Before starting liver resection, pneumoperitoneum is quitted to avoid possible CO2 embolism through the cut surface of the liver. An 8-12cm of sub-costal mini-laparotomy is made, and intra-operative ultrasonogram is performed to identify all the major vessels and bile ducts. We start to ligate the hepatic pedicle before parenchymal dissection. Hepatic parenchymal dissection is performed through the mini-laparotomy with a laparoscopic coagulating scissors and an ultrasonic dissector using the liver-hanging maneuver. The hepatic pedicle, short hepatic veins, and the hepatic vein are divided with GIA stapling. In donor hepatectomy, first perform parenchymal resection and then divide the bile duct, hepatic artery, portal vein and hepatic vein.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Indication for laparoscopy-assisted hepatectomy includes tumor size less than 10cm without bile duct resection or lymph node dissection.

Key exclusion criteria

All except key inclusion criteria

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Go wakabayashi

Organization

Iwate Medical University

Division name

Surgery

Zip code


Address

19-1 Uchimaru,Morioka,Iwate Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Hiroyuki Nitta

Organization

Iwate Medical University

Division name

Surgery

Zip code


Address

19-1 Uchimaru,Morioka,Iwate Japan

TEL


Homepage URL


Email



Sponsor or person

Institute

Iwate Medical University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 05 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2008 Year 05 Month 01 Day

Date of IRB


Anticipated trial start date

2008 Year 05 Month 01 Day

Last follow-up date

2013 Year 05 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2008 Year 05 Month 15 Day

Last modified on

2008 Year 05 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001408


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name